PHMMF
Price
$102.08
Change
-$3.52 (-3.33%)
Updated
Mar 6 closing price
Capitalization
1.8B
WVE
Price
$9.15
Change
-$0.25 (-2.66%)
Updated
Mar 10, 03:26 PM (EDT)
Capitalization
1.44B
59 days until earnings call
Ad is loading...

PHMMF vs WVE

Header iconPHMMF vs WVE Comparison
Open Charts PHMMF vs WVEBanner chart's image
Pharma Mar SA
Price$102.08
Change-$3.52 (-3.33%)
Volume$100
Capitalization1.8B
Wave Life Sciences
Price$9.15
Change-$0.25 (-2.66%)
Volume$400
Capitalization1.44B
PHMMF vs WVE Comparison Chart
Loading...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHMMF vs. WVE commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHMMF is a Hold and WVE is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (PHMMF: $105.60 vs. WVE: $11.23)
Brand notoriety: PHMMF and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHMMF: 20% vs. WVE: 231%
Market capitalization -- PHMMF: $1.71B vs. WVE: $1.44B
PHMMF [@Biotechnology] is valued at $1.71B. WVE’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHMMF’s FA Score shows that 1 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • PHMMF’s FA Score: 1 green, 4 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, PHMMF is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WVE’s TA Score shows that 5 TA indicator(s) are bullish.

  • WVE’s TA Score: 5 bullish, 2 bearish.

Price Growth

PHMMF (@Biotechnology) experienced а +10.24% price change this week, while WVE (@Biotechnology) price change was +8.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

WVE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHMMF($1.8B) has a higher market cap than WVE($1.44B). PHMMF YTD gains are higher at: 30.258 vs. WVE (-9.216). PHMMF has higher annual earnings (EBITDA): 5.34M vs. WVE (-143.36M). WVE has more cash in the bank: 311M vs. PHMMF (144M). WVE has less debt than PHMMF: WVE (27.2M) vs PHMMF (38.5M). PHMMF has higher revenues than WVE: PHMMF (167M) vs WVE (53.6M).
PHMMFWVEPHMMF / WVE
Capitalization1.8B1.44B125%
EBITDA5.34M-143.36M-4%
Gain YTD30.258-9.216-328%
P/E Ratio63.52N/A-
Revenue167M53.6M312%
Total Cash144M311M46%
Total Debt38.5M27.2M142%
FUNDAMENTALS RATINGS
PHMMF vs WVE: Fundamental Ratings
PHMMF
WVE
OUTLOOK RATING
1..100
4869
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
5975
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3540
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHMMF's Valuation (3) in the null industry is somewhat better than the same rating for WVE (67) in the Biotechnology industry. This means that PHMMF’s stock grew somewhat faster than WVE’s over the last 12 months.

PHMMF's Profit vs Risk Rating (59) in the null industry is in the same range as WVE (75) in the Biotechnology industry. This means that PHMMF’s stock grew similarly to WVE’s over the last 12 months.

PHMMF's SMR Rating (100) in the null industry is in the same range as WVE (100) in the Biotechnology industry. This means that PHMMF’s stock grew similarly to WVE’s over the last 12 months.

PHMMF's Price Growth Rating (35) in the null industry is in the same range as WVE (40) in the Biotechnology industry. This means that PHMMF’s stock grew similarly to WVE’s over the last 12 months.

PHMMF's P/E Growth Rating (100) in the null industry is in the same range as WVE (100) in the Biotechnology industry. This means that PHMMF’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
WVE
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
87%
Momentum
ODDS (%)
Bullish Trend 7 days ago
87%
MACD
ODDS (%)
Bullish Trend 7 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
85%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
89%
Aroon
ODDS (%)
Bearish Trend 7 days ago
86%
View a ticker or compare two or three
Ad is loading...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

PHMMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHMMF has been loosely correlated with DRUG. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PHMMF jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHMMF
1D Price
Change %
PHMMF100%
N/A
DRUG - PHMMF
44%
Loosely correlated
-7.70%
PRQR - PHMMF
36%
Loosely correlated
-5.16%
ATNF - PHMMF
33%
Poorly correlated
-10.00%
CTCX - PHMMF
30%
Poorly correlated
-12.68%
WVE - PHMMF
29%
Poorly correlated
+11.74%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+11.74%
PRQR - WVE
53%
Loosely correlated
-5.16%
KRRO - WVE
46%
Loosely correlated
-5.10%
ATNF - WVE
38%
Loosely correlated
-10.00%
KYMR - WVE
37%
Loosely correlated
+1.69%
VYGR - WVE
37%
Loosely correlated
+1.28%
More